STAT July 22, 2024
Following a two-year probe, the European Commission has formalized a proposal from Vifor Pharma to resolve allegations that the company spread misleading information about a rival treatment to its blockbuster drug for iron deficiency.
The move came after a complaint that Vifor may have disparaged its “closest and, potentially, only” competitor to its Ferinject medicine in the European market. Specifically, the global drug company was accused of running a “misleading communication campaign,”...
Today's Sponsors
Today's Sponsor